Oaktree Specialty Lending Corpo (OCSL) stock price moved 3.34% away from 20-Days Simple Moving Average, -0.01% from 50-Days Simple Moving Average and separated -4.44% from 200 Days Simple Moving Average. Oaktree Specialty Lending Corpo (OCSL) reported loss -0.44% in recent buying and selling session with closing price of $ 4.48. The stock’s traded 0.15 million shares in session while it holds an average volume of 0.46 million shares. The OCSL switched 9.80% away from its 52 week minimum and distanced -12.84% from its 52 week peak. The volatility change in the previous week has observed by 1.92% and experienced of 2.92% change in the last month.
The short ratio in the company’s stock is documented at 0.78 and the short float is around of 0.31%. Beta factor, which measures the riskiness of the security, was registered at 0.50. The Company kept a record of 113.86 million floated shares and 141.58 million shares outstanding. The average true range of the stock is observed at 0.12 and the relative strength index of the stock is recorded at 53.34.
Oaktree Specialty Lending Corpo (OCSL) Stock Profitability Levels:
Net profit margin of the company is seen at 33.70%. Operating profit margin is positioned at 43.30%. Gross profit margin is 72.00%. The larger the gross profit margin, the better for the company. The company made Return on equity of 5.60% in last 12 months period. Return on assets ratio of the Company was 3.10%. Its return on investment ratio was 4.70% in the trailing 12 months period.
The Company’s sales have grown at an average annualized rate of about -8.90% during the past five years. For the past 5 years, The Company’s EPS growth has been nearly -18.00%. Looking out over a next 5-year period, analysts expect the company to see its earnings go up by 2.00%, annually. Analyst established EPS growth expected to grow of 123.80% for this year and EPS growth for next year is likely to attain at 9.91%.
Looking about the past performance history, the company plunged 1.36% for the last five trades and exhausted -0.22% in one month period. The stock deteriorated -7.25% during the past three month period and discounted -4.27% in half year. During the yearly overview it downgraded -8.38% and shown 5.91% year to date performance.